ARRY-380 + Trastuzuamab for Breast w/ Brain Mets

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Array BioPharma
Breast Cancer Research Foundation
Information provided by (Responsible Party):
Nancy Lin, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01921335
First received: August 2, 2013
Last updated: March 31, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2019
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)